Home › Prostate Cancer › NCT05351424
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Recruiting
Audiovisual Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Pilot Phase Inclusion Criteria: 1. Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 2. Currently undergoing treatment for breast or prostate cancer, or recently been treated Pilot Phase Exclusion Criteria: 1. Patient with bilateral deafness and/or blindness 2. Patient with psychosis and/or dementia Main Study Inclusion Criteria: 1. Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 2. Patients with non-metastatic prostate or breast cancer 3. Histopathologically proven diagnosis of prostate or breast cancer 4. History and physical examination within 28 days prior to enrollment 5. Karnofsky performance status 70 or greater 6. For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines 7. Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit. 8. Consultation visit must be performed with a certified interpreter Main Study Exclusion Criteria: 1. Patient with bilateral deafness and/or blindness 2. Patient with psychosis and/or dementia 3. Clinical or radiological evidence of metastatic disease 4. Prior participation in cancer patient education trial 5. Prior RT 6. RT for sites other than breast or prostate
About the study
The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.
What is being tested
- Audiovisual Intervention- Radiation Therapy Education (other)
- ASTRO Radiation Therapy for Breast or Prostate Cancer Brochure (other)
- Audiovisual Intervention- Cancer Clinical Trials Education (other)
- NCI Taking Part in Cancer Research Studies Brochure (other)
Sponsor: Columbia University · Participants: 194 · Started: May 3, 2022
Contact the study team
- Christina Chesnakov, MPH · Phone: 646-317-4244
Official record on ClinicalTrials.gov — NCT05351424
Locations in the U.S.
| Florida | Mount Sinai Medical Center, Miami Beach |
| New York | Columbia University Irving Medical Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.